×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agenda
Development of a New Patient-reported Outcome (PRO) Measure for Depression: Progress and Results from the PRO Consortium
Session Chair(s)
Stephen Joel Coons, PhD
Senior Advisor
Critical Path Institute, United States
Gain an understanding of the research conducted by the PRO Consortium’s Depression Working Group to develop a new patient-reported outcome (PRO) measure for depression which is intended for use as an endpoint to support medical product labeling.
Learning Objective : Discuss the FDA criteria for evaluating and qualifying patient-reported outcome (PRO) measures; Discuss the results of qualitative research conducted to support development of a new clinical trial endpoint measure; Describe how multiple stakeholders have collaborated to develop a PRO measure in a pre-competitive environment.
Speaker(s)
Panelist
Elektra Papadopoulos, MD, MPH
AbbVie, United States
Director, Patient Experience Data and Strategy
Key Findings from Systematic Reviews of Published Literature and Existing Instruments
Steven I. Blum, MA, MBA
Forest Research Institute, United States
Director, Health Economics
Panelist
Mona L. Martin, MPA, RN
Health Research Associates, United States
Executive Director
Have an account?